Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
Public ClinicalTrials.gov record NCT07828860. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b, Open-label Study Evaluating the Safety and Efficacy of Oral Soquelitinib in Adults With Moderate-to-Severe Hidradenitis Suppurativa
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Safety and Efficacy of Soquelitinib in Adults with Hidradenitis Suppurativa
Study identification
- NCT ID
- NCT07828860
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 25 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 16, 2026
- Primary completion
- Nov 30, 2027
- Completion
- Nov 30, 2027
- Last update posted
- Sep 21, 2026
2026 – 2027
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Site 9 | West Lafayette | Indiana | 47906 | Not yet recruiting |
| Clinical Site 1 | Bowling Green | Kentucky | 42104 | Recruiting |
| Clinical Site 2 | Owensboro | Kentucky | 42303 | Recruiting |
| Clinical Site 3 | Boston | Massachusetts | 02215 | Not yet recruiting |
| Clinical Site 5 | New York | New York | 10023 | Recruiting |
| Clinical Site 4 | The Bronx | New York | 10455 | Recruiting |
| Clinical Site 11 | Fargo | North Dakota | 58103 | Not yet recruiting |
| Clinical Site 10 | Mayfield Heights | Ohio | 44124 | Recruiting |
| Clinical Site 6 | Camp Hill | Pennsylvania | 17011 | Not yet recruiting |
| Clinical Site 8 | Philadelphia | Pennsylvania | 19103 | Not yet recruiting |
| Clinical Site 7 | Nashville | Tennessee | 37211 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07828860, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 21, 2026 · Synced Sep 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07828860 live on ClinicalTrials.gov.